Which has the lower trailing P/E, ANIP or NUTX?

NUTX has the lower trailing P/E: ANIP trades at 15.44 and NUTX at 8.74. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANIP or NUTX?

Over the past five years, NUTX grew revenue faster — ANIP at a 35.61% CAGR versus NUTX at 37.66%.

Is ANIP or NUTX more profitable?

NUTX runs the higher net margin — ANIP at 10.82% versus NUTX at 21.25%.

How have ANIP and NUTX total returns compared?

Over the past 10 years, ANIP delivered 0.51% and NUTX delivered -27.99% annualized total return. Past performance doesn't predict future results.

ANI Pharmaceuticals, Inc. (ANIP) vs Nutex Health, Inc. (NUTX)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and Nutex Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANIP

ANI Pharmaceuticals, Inc.

$1.62B

$71.47HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

NUTX

Nutex Health, Inc.

$1.52B

$221.01HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT

Total return — ANIP vs NUTX

growth of $100 · dividends reinvested · last 10y

ANIP +5.2% (+0.5%/yr)NUTX -96.6% (-28.6%/yr)ANIP compounded faster over this window

Log scale — wide-divergence pair

ANIP NUTX

ANIP vs NUTX: by the numbers

•ANIP is the larger company ($1.62B vs $1.52B market cap).
•NUTX trades at the lower trailing earnings multiple (8.74 vs 15.44 P/E), one valuation lens rather than an overall verdict.
•NUTX converts more revenue to profit (21.25% vs 10.82% net margin).
•NUTX grew revenue faster over the past five years (37.66% vs 35.61% CAGR).

Metrics side by side

Valuation

Metric	ANIP	NUTX
P/E ratio	15.44	8.74
Forward P/E	7.71	7.95
P/S ratio	1.66	1.80
P/B ratio	2.72	3.86
EV / EBITDA	6.76	4.32
FCF yield	N/A	18.03%

Profitability

Metric	ANIP	NUTX
Gross margin	51.01%	51.26%
Operating margin	15.35%	31.49%
Net margin	10.82%	21.25%
ROE	17.72%	45.63%
ROIC	9.26%	33.76%

Growth (annualized)

Metric	ANIP	NUTX
Revenue CAGR (5Y)	35.61%	37.66%
EPS CAGR (5Y)	N/A	-14.73%
Total return CAGR (5Y)	16.86%	-18.99%

Frequently asked

Which has the lower trailing P/E, ANIP or NUTX?: NUTX has the lower trailing P/E: ANIP trades at 15.44 and NUTX at 8.74. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANIP or NUTX?: Over the past five years, NUTX grew revenue faster — ANIP at a 35.61% CAGR versus NUTX at 37.66%.
Is ANIP or NUTX more profitable?: NUTX runs the higher net margin — ANIP at 10.82% versus NUTX at 21.25%.
How have ANIP and NUTX total returns compared?: Over the past 10 years, ANIP delivered 0.51% and NUTX delivered -27.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIP analysis Full NUTX analysis Interactive comparison tool

Dig into the metrics

ANI Pharmaceuticals P/E ratio Nutex Health P/E ratio ANI Pharmaceuticals ROE Nutex Health ROE ANI Pharmaceuticals operating margin Nutex Health operating margin ANI Pharmaceuticals revenue growth Nutex Health revenue growth ANI Pharmaceuticals free cash flow Nutex Health free cash flow

ANI Pharmaceuticals & Nutex Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.